期刊文献+

冠状动脉多支病变DES与CABG的疗效观察 被引量:1

Effects of Drug Eluting Stents and Coronary Artery Bypass Grafting on Multi-Branches Lesions of Coronary Arteries
下载PDF
导出
摘要 目的:观察药物洗脱支架(DES)和冠状动脉旁路移植术(CABG)对冠状动脉多支病变的疗效。方法:220例多支病变冠心病(CHD)患者接受DES(148例)或CABG(72例),观察围术期疗效、并发症,进行临床随访了解远期疗效(再发心绞痛、再次血运重建、死亡、无事件存活等)。结果:围手术期DES和CABG的手术成功率均较高,两组间差异无统计学意义(P>0.05)。心力衰竭发生率CABG组高于DES组,差异有统计学意义(P<0.05);死亡、脑梗塞、心绞痛、多脏器功能衰竭发生率两组间无明显差异(P>0.05)。术后(12±6.7)个月随访结果示:DES组的再发心绞痛、靶血管重建高于CABG组,差异有统计学意义(P<0.05)。非致死性心肌梗死、新发心力衰竭、脑血管病、心脏性死亡、无事件存活率等两组间差异无统计学意义(P>0.05)。结论:CHD多支冠状动脉病变患者,CABG和DES的手术成功率均较高,近期疗效无明显区别。远期疗效观察,两组死亡率无明显区别,但CABG组的再发心绞痛及靶血管重建小于DES组。 Objective: To observe the clinical effects of drug eluting stents(DES) and coronary artery bypass grafting (CABG) on multi-branches lesions of coronary arteries. Methods:220 cases of multi-branches lesions of coronary arteries was treated with DES(148) or CABG(72). The effects of DES and CABG were observed. The perioperative and long-term compliments were also observed, such as recurrent angina pectoris, target vessel rebuilding, death and non-event existence. Results:The similar higher success rates of DES and CABG were observed in these patients immeditately after operation(P〉0.05), The incidence of heart failure in perioperative period was higher in CABG group than in DES group(P〈0.05), but there were no significant differences between two groups in the incidences of cerebral infarction, angina peetoris and multiple system organ failure(P〉0.05). Long-term follow-up(12a=6.7 months) results showed that the incidences of recurrent angina pectoris and target vessel rebuilding in DES group were higher than in CABG group(P〈0.05), and there were no significant differences of non-fatal myocardial infarction, new attack of heart failure,cerebral vessel diseases, cardiogenic death and non-event existence between the two groups(P〉0.05). Conclusions:The success rates of DES and CABG were similar in the patients of multi-branches lesions of coronary arteries, and there were no significant differences of two groups in perioperative period. The mortality rate of of the two groups in the long-term were also similar, but the incidence of recurrent angina pectoris and target vessel rebuilding were higher in DES group than in CABG group.
出处 《中国医药导刊》 2010年第8期1283-1284,共2页 Chinese Journal of Medicinal Guide
基金 洛阳市科研基金(编号:200701048A)
关键词 冠状动脉多支病变 药物洗脱支架 冠状动脉旁路手术 Multi-branches lesions of coronary artery Drug eluting stents Coronary artery bypass grafting
  • 相关文献

参考文献5

二级参考文献53

  • 1李芳,王琳,卜军.替罗非班治疗急性冠脉综合征的临床研究[J].内科急危重症杂志,2004,10(2):72-74. 被引量:17
  • 2郝恒剑,李康,李耘,魏嘉平,汪家瑞.冠状动脉介入治疗后快速进展性冠状动脉狭窄的探讨[J].中国介入心脏病学杂志,2004,12(4):222-223. 被引量:3
  • 3李浪,Tan HuayCheem,Teo SweeGuan,Lim YeanTeng.远端血栓保护装置PercuSurge用于急性冠状动脉综合征经皮冠状动脉介入治疗[J].中国介入心脏病学杂志,2004,12(4):224-227. 被引量:3
  • 4杨新春,张大鹏,王乐丰,徐立,葛永贵,王红石,李惟铭,倪祝华,夏昆,连勇,薛永利,马利祥.冠状动脉内应用国产替罗非班对急性ST段抬高心肌梗死急诊介入治疗后心肌灌注和临床预后的影响[J].中华心血管病杂志,2007,35(6):517-522. 被引量:73
  • 5Schofer J,Schluter M,Gershlick AH,et al.Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries:double-blind,randomised controlled trial (E-SIRIUS).Lancet,2003,362:1093-1099.
  • 6Schampaert E,Cohen EA,Schluter M,et al.The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS).J Am Coll Cardio,2004,43:1110-1115.
  • 7Stone GW,Ellis SG,Cox DA,et al.One-year clinical results with the slow-release,polymer-based,paclitaxel-eluting TAXUS stent:the TAXUS-Ⅳ trial.Circulation,2004,109:1942-1947.
  • 8Smith SC Jr,Dove JT,Jacobs AK,et al.ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)--executive summary.A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty).J Am Coll Cardiol,2001,37:2215-2239.
  • 9Williams DO,Holubkov R,Yeh W,et at.Percutaneous coronary intervention in the current era compared with 1985-1986:the National Heart,Lung,and Blood Institute Registries.Circulation,2000,102:2910-2914.
  • 10Dibra A,Kastrati A,Mehilli J,et al.Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients:the ISAR-DIABETES Trial.N Engl J Med,2005,353:663-670.

共引文献19

同被引文献11

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部